(Formerly the Office of the Chief Scientist and MATIMOP)
 
SEARCH
 
 
 

Call for Proposals 4 with BD

 

     


Call for Proposals with BD
     

Call no. 4:

New Technology to Improve Medical Device Performance

& Health Care Delivery

 

A call for proposals is being launched in the framework of the Global Enterprise R&D Collaboration Agreement between the Office of the Chief Scientist (OCS) of the Ministry of Economy and BD.  BD is a large medical device company serving healthcare needs around the world, in both high- and low- resource settings.  BD is seeking new technologies to satisfy unmet needs .

Low-cost solutions for rapid and robust biometric patient identification (Proposal 4.1)

BD seeks to identify technologies for low-cost biometric patient identification, in order to provide unambiguous identification of patients with their electronic medical records and to support transportability of records between points of care.  Solutions of interest will address considerations of cost, data acquisition speed, data processing speed, technology availability (application of existing tools preferred), form factor, and patient comfort.  Solutions that take different approaches for different populations (e.g. adults with discernible fingerprints vs. infants/children vs. physical laborers) will be considered. Approaches that require patients to present an extrinsic identifier or that require embedding or applying an identifier will not be considered.  Preference will be given to tools that utilize or easily interface with smart mobile devices such as laptops, tablets, and smart phones.  Approaches that will be considered include:

  1. Analysis of structural features
  2. Analysis of features in the eye / iris
  3. Analysis of hand / eye prints
  4. Other biometric identifiers
  5. Use of cameras or fingerprint readers built into cell phones

 

Very low cost solutions for labeling/tagging medical supplies with unique identifiers (Proposal 4.2)

BD seeks to identify technologies for low-cost non-powered (i.e., no power store on tag) tagging of individual medical supplies with unique identifiers that can be detected by a reader that does not require line-of-sight.  Solutions of interest will address considerations of cost, form factor, data capacity, standoff distance options (near, far, or both), reading of collocated tags, method of tag application to device, and robustness to environmental conditions. Tags and readers may not interfere with the operation of nearby medical equipment.  Solutions of interest include:

  1. Low-cost (below $0.01 USD) RFID tags that are compatible with all standard RFID frequency bands and RFID (or NFC as appropriate) readers
  2. Low-cost (below $0.01 USD) RFID tags that are compatible with only select RFID frequency bands and standard RFID (or NFC as appropriate) readers
  3. Low-cost (below $0.01 USD) RFID tags that require non-standard RFID/NFC readers
  4. Low-cost (below $0.01 USD) identification tags utilizing identification or detection modalities other than RFID
  5. Tags which are able to withstand standard sterilization processes, including: steam (15 minutes at 124 degrees C in saturated steam at 200 kPa air pressure; or up to: 5 minutes at 138 degrees C in saturated steam at 300 kPa); chemical (Ethylene oxide); and radiation (E-beam, X-ray, and Gamma)
  6. Tags that provide functionalities in addition to identification

 

Circle of Care Engagement Platform (Proposal 4.3)

BD seeks a cloud based platform supporting both web and mobile that is disease and data type agnostic and can be dynamically customized for each participant / disease area.  For example, participants with diabetes might be interested in data from the following types of devices: insulin pen, oral medication tracker, blood glucose meter or continuous glucose monitor, activity monitor, nutrition data, geo-location data and mood/stress data. Successful architectures will be extensible and scalable.  We expect the system to run in a cloud-based environment such as Azure or AWS and be able to meet regulatory and privacy requirements as applicable in deployed locales.   There are many existing examples of personal health related portals (HealthVault, Google Health, SAMI).

The portal should be designed so it can enable a typical range of interactions, for instance, as illustrated below.

           

Figure 1: “Checking on a family member’s adherence to treatment/wellness regimen” is a lot harder than it sounds.

Given a very simple network of an extended family (see Figure 1), any member shown may be interested in monitoring the well-being of another in the network. For instance C1 may be interested in seeing how well A3 is adhering to his cholesterol medication and activity regimen, B3 and B4 need to monitor how well their daughter, C3, is adhering to her Type 1 diabetes treatment (e.g. from making sure she is checking her blood sugar regularly to confirming that she is taking the right insulin dose);
B3 and B4 are also interested in monitoring their parents, A3 & A4 (both in a nursing home) and A5 & A6, respectively.

BD seeks to develop a “family health portal” that aggregates medical device and wellness data of the family members and presents the information in a customizable manner. Specifically, we would like to see a two part proposal:

I.         Develop a “minimum viable system” that comprises the following modules (for the patient):

(i)                   Preventive and wellness: Appointments (Dr’s visits, dentists, eye Dr’s etc.)

(ii)                 Patient self-test results (with programmable targets or desired ranges for patient)

a. BP, HR, weight, diet

b. BGM, CGM

(iii)                Medication administration (relative to an assumed prescription schedule)

a. Orals

b. Injections

(iv)               Appropriate security protocols

(v)                 Mechanism(s) for monitoring of (i)-(iii) and subsequent notification of the patient

II.       A test case to demonstrate the viability of the system.

 

---------------------------------------------------------------------------------

 

For all proposals :

The proposals will be evaluated on (a) scalability of the approaches chosen and the platform nature of the “minimum viable prototypes”  and (b) the richness of the test cases proposed. Further, a reasonable assessment of the pathway from prototype to implementation should be completed.

 

Companies that are interested in applying should send a summary proposal to Adam_Curry@bd.com for Proposals 4.1 & 4.2, or Dylan_Wilson@bd.com for Proposal 4.3, with a copy to Noam.BarGal@ocs.economy.gov.il .

Proposals will be evaluated by the Office of the Chief Scientist and BD.Companies whose proposals are found suitable will be invited to submit requests for support within the Chief Scientist's Framework for R&D Cooperation with Multinational Companies. Approved applications will receive the following assistance:

·         A Chief Scientist Grant of up to 50% of the project's approved budget;

·         Additional assistance from BD of the same budget amount in-kind, for support in the technological and regulatory areas; use of laboratory equipment for R&D; sub-contractors and professional consultants; etc.

 

For more information on BD activities, please visit the corporate website at: http://www.bd.com .